CN104245676B - 用于制备3,5-双(氟烷基)吡唑-4-甲酸衍生物和3,5-双(氟烷基)吡唑类化合物的方法 - Google Patents

用于制备3,5-双(氟烷基)吡唑-4-甲酸衍生物和3,5-双(氟烷基)吡唑类化合物的方法 Download PDF

Info

Publication number
CN104245676B
CN104245676B CN201380007228.7A CN201380007228A CN104245676B CN 104245676 B CN104245676 B CN 104245676B CN 201380007228 A CN201380007228 A CN 201380007228A CN 104245676 B CN104245676 B CN 104245676B
Authority
CN
China
Prior art keywords
mmol
mixture
room temperature
difluoromethyl
stirred
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201380007228.7A
Other languages
English (en)
Chinese (zh)
Other versions
CN104245676A (zh
Inventor
S.帕泽诺克
N.卢伊
J-P.沃尔
F.R.勒鲁
F.焦尔纳尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer CropScience AG
Centre National de la Recherche Scientifique CNRS
Original Assignee
Bayer CropScience AG
Centre National de la Recherche Scientifique CNRS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer CropScience AG, Centre National de la Recherche Scientifique CNRS filed Critical Bayer CropScience AG
Publication of CN104245676A publication Critical patent/CN104245676A/zh
Application granted granted Critical
Publication of CN104245676B publication Critical patent/CN104245676B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/30Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and unsaturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
CN201380007228.7A 2012-02-01 2013-01-31 用于制备3,5-双(氟烷基)吡唑-4-甲酸衍生物和3,5-双(氟烷基)吡唑类化合物的方法 Active CN104245676B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12356001.3A EP2623496A1 (de) 2012-02-01 2012-02-01 Verfahren zur Herstellung von 3,5-bis (fluoralkyl)-pyrazol-4-carbonsäure-Derivaten und 3,5-bis(fluoralkyl)-pyrazolen
EP12356001.3 2012-02-01
PCT/EP2013/051930 WO2013113829A1 (de) 2012-02-01 2013-01-31 Verfahren zur herstellung von 3,5-bis(fluoralkyl)-pyrazol-4-carbonsäure-derivaten und 3,5-bis(fluoralkyl)-pyrazolen

Publications (2)

Publication Number Publication Date
CN104245676A CN104245676A (zh) 2014-12-24
CN104245676B true CN104245676B (zh) 2016-09-21

Family

ID=47624109

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201380007228.7A Active CN104245676B (zh) 2012-02-01 2013-01-31 用于制备3,5-双(氟烷基)吡唑-4-甲酸衍生物和3,5-双(氟烷基)吡唑类化合物的方法

Country Status (13)

Country Link
US (2) US9309202B2 (enExample)
EP (2) EP2623496A1 (enExample)
JP (1) JP6155283B2 (enExample)
KR (1) KR101861116B1 (enExample)
CN (1) CN104245676B (enExample)
BR (1) BR112014019036B1 (enExample)
DK (1) DK2809653T3 (enExample)
ES (1) ES2647348T3 (enExample)
IL (1) IL233926B (enExample)
IN (1) IN2014DN07129A (enExample)
MX (1) MX362689B (enExample)
TW (1) TWI609006B (enExample)
WO (1) WO2013113829A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014187774A1 (de) * 2013-05-22 2014-11-27 Bayer Cropscience Ag Verfahren zur herstellung von 3,5-bis(fluoralkyl)-pyrazol-derivaten
TWI647215B (zh) * 2013-11-11 2019-01-11 德商拜耳作物科學股份有限公司 自α,α-二鹵胺製備3,5-雙鹵烷基吡唑衍生物之方法
EP3015458A1 (en) * 2014-11-03 2016-05-04 Bayer CropScience AG Process for preparing 3,5-bis(haloalkyl)pyrazole derivatives from a,a-dihaloamines and ketimines
JP6431088B2 (ja) * 2014-03-24 2018-11-28 バイエル・クロップサイエンス・アクチェンゲゼルシャフト α,α−ジハロアミン類およびケチミン類からの3,5−ビス(ハロアルキル)ピラゾール誘導体の製造方法
BR112016028700B1 (pt) * 2014-06-11 2021-03-23 Bayer Cropscience Aktiengesellschaft Processo para preparação de 3,5-bis(haloalquil)pirazóis via acilação de cetiminas
ES2672577T3 (es) 2014-06-11 2018-06-15 Bayer Cropscience Aktiengesellschaft Proceso para preparar derivados de 3,5-bis(haloalquil)pirazol por medio de la acilación de Hidrazonas
CR20170413A (es) 2015-02-11 2018-02-06 Basf Se Mezcla plaguicida que comprende un compuesto pirazol, un insecticida y un fungicida
EP3313820A1 (en) * 2015-06-26 2018-05-02 Bayer CropScience Aktiengesellschaft Process for preparing substituted pyrazoles containing haloalkoxy- and haloalkylthio groups from , -dihaloalkylamines and ketimines
TW202014410A (zh) 2018-06-18 2020-04-16 德商拜耳廠股份有限公司 二取代的5(3)-吡唑羧酸酯及由烯醇鹽與氟烷基胺基試劑(far)製備其之方法
US11014945B2 (en) * 2019-04-06 2021-05-25 Trinapco, Inc. Sulfonyldiazoles and N-(fluorosulfonyl)azoles, and methods of making the same

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1871204A (zh) * 2003-10-23 2006-11-29 拜尔农作物科学股份公司 制备2-二卤代酰基-3-氨基丙烯酸酯以及3-二卤代甲基吡唑-4-羧酸酯的方法
CN101228156A (zh) * 2005-07-26 2008-07-23 杜邦公司 杀真菌甲酰胺

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2004460A6 (es) * 1987-07-29 1989-01-01 Consejo Superior Investigacion Procedimiento para la preparacion de derivados de 3-5-bis-(halometil) pirazol
JP3533134B2 (ja) * 1999-02-15 2004-05-31 三井化学株式会社 フッ素化剤及びその製法と使用
JP2001192369A (ja) * 2000-01-12 2001-07-17 Mitsui Chemicals Inc フッ素含有複素環式芳香族化合物の製造方法および新規ピラゾール環化合物
DE10215292A1 (de) 2002-02-19 2003-08-28 Bayer Cropscience Ag Disubstitutierte Pyrazolylcarbocanilide
US7842693B2 (en) * 2002-06-12 2010-11-30 Chemocentryx, Inc. Substituted piperazines
GB0526044D0 (en) * 2005-12-21 2006-02-01 Syngenta Ltd Novel herbicides
WO2008013622A2 (en) 2006-07-27 2008-01-31 E. I. Du Pont De Nemours And Company Fungicidal azocyclic amides
DE102006039909A1 (de) 2006-08-25 2008-03-13 Bayer Cropscience Ag Verfahren zum Herstellen von 3-Dihalomethyl-pyrazol-4-carbonsäurederivaten
WO2008091594A2 (en) * 2007-01-24 2008-07-31 E. I. Du Pont De Nemours And Company Fungicidal mixtures
EP2133341A1 (de) 2008-02-25 2009-12-16 Bayer CropScience AG Verfahren zur regioselektiven Synthese von 1-Alkyl-3-haloalkyl-pyrazol-4-carbonsäure-Derivaten
EP2100883A1 (de) 2008-03-10 2009-09-16 Bayer CropScience AG Verfahren zur regioselektiven Synthese von 1-Alkyl-3-haloalkyl-pyrazol-4carbonsäure-Derivaten
JP2010083763A (ja) * 2008-09-29 2010-04-15 Mitsui Chemicals Inc ピラゾール誘導体およびその製造方法、ならびに殺菌剤

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1871204A (zh) * 2003-10-23 2006-11-29 拜尔农作物科学股份公司 制备2-二卤代酰基-3-氨基丙烯酸酯以及3-二卤代甲基吡唑-4-羧酸酯的方法
CN101228156A (zh) * 2005-07-26 2008-07-23 杜邦公司 杀真菌甲酰胺

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Reaction of 1,1,2-trifluoro-2-chloroethyl-N,N-diethylamine with N,N-dichloroarene-sulfamides and some compounds with mobile hydrogen-atoms;Yagupolskii等;《Zh. Organicheskoi Khim.》;19781231;第14卷(第12期);第2493-2496页 *

Also Published As

Publication number Publication date
DK2809653T3 (da) 2017-11-27
US9309202B2 (en) 2016-04-12
JP6155283B2 (ja) 2017-06-28
TWI609006B (zh) 2017-12-21
KR20140128344A (ko) 2014-11-05
CN104245676A (zh) 2014-12-24
EP2809653B1 (de) 2017-08-16
MX362689B (es) 2019-02-01
TW201336826A (zh) 2013-09-16
US10035773B2 (en) 2018-07-31
JP2015511227A (ja) 2015-04-16
BR112014019036A2 (pt) 2017-08-22
ES2647348T3 (es) 2017-12-21
KR101861116B1 (ko) 2018-05-25
EP2809653A1 (de) 2014-12-10
IL233926A0 (en) 2014-09-30
IL233926B (en) 2018-08-30
IN2014DN07129A (enExample) 2015-04-24
US20150011779A1 (en) 2015-01-08
MX2014009203A (es) 2014-11-12
US20160185731A1 (en) 2016-06-30
EP2623496A1 (de) 2013-08-07
BR112014019036B1 (pt) 2019-10-08
WO2013113829A1 (de) 2013-08-08

Similar Documents

Publication Publication Date Title
CN104245676B (zh) 用于制备3,5-双(氟烷基)吡唑-4-甲酸衍生物和3,5-双(氟烷基)吡唑类化合物的方法
CN101970412B (zh) 区域选择性地制备1-烷基-3卤代烷基吡唑-4-羧酸衍生物的方法
KR102140620B1 (ko) 3,5-비스(할로알킬)-피라졸-4-카복실산 유도체의 탈카복실화 방법
KR102291770B1 (ko) α,α-디할로아민으로부터 3,5-비스(할로알킬)피라졸 유도체의 제조방법
JP6431088B2 (ja) α,α−ジハロアミン類およびケチミン類からの3,5−ビス(ハロアルキル)ピラゾール誘導体の製造方法
JP6514722B2 (ja) ケチミン類のアシル化を介した3,5−ビス(ハロアルキル)ピラゾール類の製造方法
JP6530428B2 (ja) ヒドラゾン類のアシル化を介した3,5−ビス(ハロアルキル)ピラゾール誘導体の製造方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant